BERWYN, Pa., Feb. 6, 2018 /PRNewswire/ — RM LAW, P.C. is investigating potential claims against the board of directors of Cascadian Therapeutics, Inc. (“Cascadian Therapeutics” or the “Company”) (NASDAQ: CASC) concerning possible breaches of fiduciary duty and other violations of law…
